Cobalt and CMS advised SYNLAB International GmbH on the sale of all shares in SYNLAB Lietuva. Affidea Lietuva, a healthcare group owned by the Dutch capital...
Affidea’s Acquisition of Synlab Lietuva Laboratory Network
Mars’ Acquisition of SYNLAB’s Veterinary Diagnostics Business
CMS advised SYNLAB on sale of veterinary diagnostics business to Mars. The SYNLAB Group, a prominent provider of medical diagnostic services and specialized tests in Europe,...
Sonic Healthcare’s Acquisition of SYNLAB Suisse SA
CMS advised SYNLAB on the sale of its Swiss business to Sonic Healthcare. SYNLAB and Sonic Healthcare have announced the sale of SYNLAB Suisse SA to...
SYNLAB Group’s Acquisition of WolfartKlinik Hospital in Gräfelfing
CMS advised SYNLAB on the deal. The SYNLAB Group has acquired the WolfartKlinik hospital in Gräfelfing near Munich from the Wolfart family. The transaction was agreed...
Synlab International GmbH’s Buy-out of its Nigerian Venture Partners
Aluko & Oyebode advised SYNLAB International GmbH on the deal. SYNLAB International GmbH executed a buy-out of its Nigerian venture partners in Synlab Nigeria Limited, one...
Synlab’s Initial Public Offering
Poellath advised Synlab’s board of directors on the deal. Clifford Chance has advised SYNLAB, Europe’s leading medical laboratory and diagnostic services company, and its majority shareholders...